Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Dr Seth Lederman spoke to Proactive on the group’s financial results for the fourth quarter and full year, along with an update on its second Phase 3 study of fibromyalgia.
Dr Lederman says it recently enrolled the first 50% of patients in its RALLY study. The RALLY study uses the same design as the company’s first positive Phase 3 study, RELIEF, but with an additional 200 patients. Top-line results are expected by the end of 2021.
Story by ProactiveInvestors
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video)